The Latest News & Trends
We cover the latest news, innovations, lifestyle, entertainment and, of course, our exclusive CEO Interview Series.
“Know and like your competitors; They are trying to make a living just like you” – Lynn Key, Nature’s Key
I had the pleasure to interview Lynn Key. Lynn is the founder of Nature’s Key one of Oklahoma’s largest edibles companies. At 61 years old, Lynn left her office job
Now what? As investors, we always have that question on our minds. Last year, cannabis enjoyed an epic rebound. After two brutal years of the longest bear market in the
“Be prepared for change… Have an open mind, and be ready to get creative.” – David Lonsdale, CanaFarma Corp.
David Lonsdale is the CEO of CanaFarma Corp., a vertically-integrated enterprise that is completely in control of its Hemp Oil products all the way from seed-to-counter. Additionally, Mr. Lonsdale is
As a part of my series about strong women leaders in the cannabis industry, I had the pleasure of interviewing Emily Kyle. Emily is an award-winning, nationally recognized media dietitian,
As a part of my series about strong women leaders in the cannabis industry, I had the pleasure of interviewing Suzanne Shpall. With a deep knowledge of design, development and
As part of my series about “5 Things I Wish Someone Told Me Before I Started Leading a Cannabis Business” I had the pleasure of interviewing Jonathan Fedele, the CEO
Federal Marijuana Legalization Is ‘Inevitable,’ Voters In States That Passed Cannabis Measures Say In New Poll
Marijuana legalization at the federal level is inevitable, and is a nonpartisan issue. That’s according to a new poll of voters in four states that opted to end cannabis prohibition
As part of my series about “5 Things I Wish Someone Told Me Before I Started Leading a Cannabis Business” I had the pleasure of interviewing Amber Laign and Marci
PRESS RELEASE: Study Shows Long-Term Cannabis Use Associated with Reduced Symptoms in Patients with Post-Traumatic Stress
Post-traumatic stress patients who consume state-authorized cannabis products exhibit reduced symptoms over time as compared to nonusers, according to longitudinal data published in the journal Cannabis and Cannabinoid Research. Commenting